Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment

Aarsland, 2009, The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease, J Neurol Neurosurg Psychiatr, 80, 928, 10.1136/jnnp.2008.166959

Alexander, 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci, 13, 266, 10.1016/0166-2236(90)90107-L

Aston, 2000, A statistical method for the analysis of positron emission tomography neuroreceptor ligand data, Neuroimage, 12, 245, 10.1006/nimg.2000.0620

Beck, 1961, Inventory for measuring depression, Arch Gen Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004

Benton, 1994, Contributions to neuropsychological assessment, 2nd edn

Bohnen, 2006, Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease, J Cereb Blood Flow Metab, 26, 1198, 10.1038/sj.jcbfm.9600276

Boileau, 2008, Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker?, J Neurosci, 28, 9850, 10.1523/JNEUROSCI.3008-08.2008

Caviness, 2007, Defining mild cognitive impairment in Parkinson’s disease, Mov Disord, 22, 1272, 10.1002/mds.21453

Chan, 1999, Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects, J Nucl Med, 40, 283

Chang, 2013, Decoding the role of the insula in human cognition: functional parcellation and large-scale reverse inference, Cereb Cortex, 23, 739, 10.1093/cercor/bhs065

Cho, 2009, rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex, PLoS One, 4, e6725, 10.1371/journal.pone.0006725

Collins, 1994, Automatic 3D intersubject registration of MR volumetric data in standardized talairach space, J Comput Assist Tomogr, 18, 192, 10.1097/00004728-199403000-00005

Cools, 2006, Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease, Neurosci Biobehav Rev, 30, 1, 10.1016/j.neubiorev.2005.03.024

Dale, 1999, Cortical surface-based analysis I. Segmentation and surface reconstruction, Neuroimage, 9, 179, 10.1006/nimg.1998.0395

Defer, 1999, Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD), Mov Disord, 14, 572, 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C

Defrise, 1997, Exact and approximate rebinning algorithms for 3-D PET data, IEEE Trans Med Imaging, 16, 145, 10.1109/42.563660

Delis, 2001, Examiner's manual for the Delis–Kaplan executive function system

Delis, 2002, Manual for the California verbal learning test, 2nd edn

Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson’s disease, Mov Disord, 22, 1689, 10.1002/mds.21507

Evans, 2004, Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome, Mov Disord, 19, 397, 10.1002/mds.20045

Fischl, 2000, Measuring the thickness of the human cerebral cortex from magnetic resonance images, Proc Natl Acad Sci USA, 9, 11050, 10.1073/pnas.200033797

Fischl, 1999, Cortical surface-based analysis II. Inflation, flattening, and a surface-based coordinate system, Neuroimage, 9, 195, 10.1006/nimg.1998.0396

Floresco, 2006, Mesocortical dopamine modulation of executive functions: beyond working memory, Psychopharmacology, 188, 567, 10.1007/s00213-006-0404-5

Frey, 1996, Presynaptic monoaminergic vesicles in Parkinson’s disease and normal aging, Ann Neurol, 40, 873, 10.1002/ana.410400609

Gelinas, 1999, Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia, Am J Occup Ther, 53, 471, 10.5014/ajot.53.5.471

Grahn, 2008, The cognitive functions of the caudate nucleus, Prog Neurobiol, 86, 141, 10.1016/j.pneurobio.2008.09.004

Gunn, 1997, Parametric imaging of ligand-receptor binding in PET using a simplified reference region model, Neuroimage, 6, 279, 10.1006/nimg.1997.0303

Haber, 2000, Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum, J Neurosci, 20, 2369, 10.1523/JNEUROSCI.20-06-02369.2000

Hilker, 2005, Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways, Neurology, 65, 1716, 10.1212/01.wnl.0000191154.78131.f6

Ito, 2001, Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain, Neuroimage, 13, 531, 10.1006/nimg.2000.0717

Kabani, 7-12 , 1998, A 3d neuroanatomical atlas, Presented at the 4th International Conference on Functional Mapping of the Human Brain

Kemmerer, 2003, Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole, Exp Neurol, 183, 81, 10.1016/S0014-4886(03)00096-7

Kilbourn, 1996, Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters, Nucl Med Biol, 23, 467, 10.1016/0969-8051(96)00023-6

Kish, 1988, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease, N Engl J Med, 318, 876, 10.1056/NEJM198804073181402

Klein, 2010, Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo, Neurology, 74, 885, 10.1212/WNL.0b013e3181d55f61

Ko, 2009, Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study, Neuroimage, 46, 516, 10.1016/j.neuroimage.2009.02.031

Koeppe, 1996, Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter, J Cereb Blood Flow Metab, 16, 1288, 10.1097/00004647-199611000-00025

Lammertsma, 1996, Simplified reference tissue model for PET receptor studies, Neuroimage, 4, 153, 10.1006/nimg.1996.0066

Litvan, 2012, Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines, Mov Disord, 27, 349, 10.1002/mds.24893

Martin, 2008, Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson’s disease, Ann Neurol, 63, 388, 10.1002/ana.21320

Mawlawi, 2001, Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum, J Cereb Blood Flow Metab, 21, 1034, 10.1097/00004647-200109000-00002

Menon, 2010, Saliency, switching, attention and control: a network model of insula function, Brain Struct Funct, 214, 655, 10.1007/s00429-010-0262-0

Meyer, 2008, Applying neuroimaging ligands to study major depressive disorder, Semin Nucl Med, 38, 287, 10.1053/j.semnuclmed.2008.02.007

Monchi, 2006, Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study, Neuroimage, 33, 907, 10.1016/j.neuroimage.2006.06.058

Monchi, 2004, Neural bases of set-shifting deficits in Parkinson’s disease, J Neurosci, 24, 702, 10.1523/JNEUROSCI.4860-03.2004

Monchi, 2007, Cortical activity in Parkinson’s disease during executive processing depends on striatal involvement, Brain, 130, 233, 10.1093/brain/awl326

Olsson, 1999, Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain, J Cereb Blood Flow Metab, 19, 1164, 10.1097/00004647-199910000-00013

Owen, 1996, A specific role for the right Parahippocampal Gyrus in the retrieval of object-location: a positron emission tomography study, J Cogn Neurosci, 8, 588, 10.1162/jocn.1996.8.6.588

Rousset, 1998, Correction for partial volume effects in PET: principle and validation, J Nucl Med, 39, 904

Rusjan, 2006, An automated method for the extraction of regional data from PET images, Psychiatry Res, 147, 79, 10.1016/j.pscychresns.2006.01.011

Scherman, 1988, [3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain, J Neurochem, 50, 1131, 10.1111/j.1471-4159.1988.tb10583.x

Seamans, 2004, The principal features and mechanisms of dopamine modulation in the prefrontal cortex, Prog Neurobiol, 74, 1, 10.1016/j.pneurobio.2004.05.006

Seeley, 2007, Dissociable intrinsic connectivity networks for salience processing and executive control, J Neurosci, 27, 2349, 10.1523/JNEUROSCI.5587-06.2007

Sridharan, 2008, A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks, Proc Natl Acad Sci USA, 105, 12569, 10.1073/pnas.0800005105

Stoessl, 2011, Neuroimaging in Parkinson’s disease, Neurotherapeutics, 8, 72, 10.1007/s13311-010-0007-z

Strafella, 2005, Corticostriatal functional interactions in Parkinson’s disease: a rTMS/[11C]raclopride PET study, Eur J Neurosci, 22, 2946, 10.1111/j.1460-9568.2005.04476.x

Talairach, 1988, Co-planar stereotaxic atlas of the human brain

Tong, 2008, Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration, Synapse, 62, 873, 10.1002/syn.20573

Van Holstein, 2011, Human cognitive flexibility depends on dopamine D2 receptor signaling, Psychopharmacology, 218, 567, 10.1007/s00213-011-2340-2

Wechsler, 1997, Manual for the Wechsler Memory Scale, 3rd edn

Wicklund, 2004, Preservation of reasoning in primary progressive aphasia: further differentiation from Alzheimer’s disease and the behavioral presentation of frontotemporal dementia, J Clin Exp Neuropsychol, 26, 347, 10.1080/13803390490510077

Wilson, 1996, Striatal dopamine nerve terminal markers in human, chronic methamphetamine users, Nat Med, 2, 699, 10.1038/nm0696-699

Woods, 1993, MRI-PET registration with automated algorithm, J Comput Assist Tomogr, 17, 536, 10.1097/00004728-199307000-00004